Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular Evidence of Rejection Intervention Trial (MERIT)
NCT07905599Not yet recruiting
- Sponsor
- CareDx
- Start
- Mar 2027
- Primary completion
- Dec 2028
01
Overview
Randomised, double-blind trial in heart transplant rejection comparing High Dose Prednisone with Placebo (2 arms). Primary endpoint: Primary Clinical Outcomes at 180 days. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
prednisone
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT07905599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07905599.